Welcome to the Applied Clinical Trials eShow Daily coming from the floor of the DIA 18th Annual EuroMeeting in Paris, France.
Welcome to the Applied Clinical Trials eShow Daily coming from the floor of the DIA 18th Annual EuroMeeting
in Paris, France.
Watch your email box for digests of the meetings most important and pertinent clinical news-gathered from sessions, press briefings and the exhibit hall.
Whether you are live at the 2006 DIA EuroMeeting this week or you are elsewhere, we hope you benefit from our daily coverage.
Do you have colleagues
and associates who
are not receiving
Applied Clinical Trials
E-Show Daily?
Have them log on to www.actmagazine.com
for the latest updates
from DIA.
Thank you, Toby J. Hindin, Editor-in-Chief.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.